Interesting cynicism from you
ALL IMO
IMO there are some key statements that are fact on the first page
"ECS is currently focussed on building its ‘seed to medicine’ model by expanding its medicinal cannabis facilities. With medicinal cannabis receiving acceptance from regulators and consumers across the globe, this market will rise rapidly providing multi-billion dollar growth opportunities. ECS takes a B2B approach in medicinal cannabis to capture greater volume and market share in Australia and overseas, while creating a local market as medicinal cannabis distributors shift to ECS for supply over Canadian imports."
"The Murray Meds acquisition has been a game changer and has already resulted in a substantial boost to ECS’s revenue in 2H FY21. Strategically, the deal enables ECS to fast-track its presence into the rapidly expanding premium dry flower market and unlock many synergistic benefits."
"ECS is well positioned to disrupt the domestic cannabis market and capture a significant share. Its low cost, adherence to UN convention, and high-quality cultivation, manufacturing and product standards are already capturing significant interest overseas."
You're entitled to your opinion...
However, ECS have started announcing offtakes to support the above statements by PSR.
It seems PSR is expecting more offtakes to come.
The report also states "Key risks that we see are (1) execution risk in scaling up its facilities;"
This statement in it self suggests there is more demand coming...
Despite what may be thought of the shareholder relations, the question is;"
Do you think Alex and the team have the ability to execute the upscaling of production?
IMO the answer to that is YES.
GLTAH
- Forums
- ASX - By Stock
- ECS
- ECS Initiation Report - Pitt Street Research
ECS Initiation Report - Pitt Street Research, page-4
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECS (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.48M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $86.21K | 4.480M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1100835 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 540000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1100835 | 0.019 |
14 | 2077812 | 0.018 |
7 | 1007480 | 0.017 |
8 | 1584448 | 0.016 |
3 | 602003 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 540000 | 3 |
0.021 | 1000000 | 2 |
0.022 | 2470000 | 6 |
0.023 | 1066453 | 4 |
0.024 | 4629265 | 8 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
1.9¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
2.0¢ | 2.0¢ | 1.9¢ | 709712 | ||
Last updated 14.48pm 06/05/2024 ? |
Featured News
ECS (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online